Sunnybrook Research Institute - Commercialization


Sunnybrook Research Institute (SRI) is active in commercializing its research. They have issued a total of 64 patents and currently have 29 active licences.

Some of their major industrial partners include GE Healthcare, Pfizer Canada Inc., Philips, sanofi pasteur and Siemens.

Several spinoff companies have emerged from SRI, including VisualSonics Inc., Sentinelle Medical Inc. and Profound Medical Inc.

Read more about this topic:  Sunnybrook Research Institute

Other articles related to "commercialization":

Molecular Scale Electronics - Problems - Commercialization
... Also problematic is the fact that some measurements on single molecules are carried out in cryogenic temperatures (close to absolute zero), which is very energy consuming ... This is done to reduce signal noise enough to measure the faint currents of single molecules ...
The Commercialization Process
... Commercialization of a product will only take place, if the following three questions can be answered When the company has to decide on the introduction timing ...
Carbon Capture And Storage (timeline) - 2007 - BP and Chinese Academy of Sciences Signed The MoU To Establish The Clean Energy Commercialization Ce
... of Understanding, announcing their intent to establish the Clean Energy Commercialization Centre ... of associated value chain investment opportunities through the commercialization of key technologies and coordinated management of large scale demonstration ...
Ali Jafari - Research and Interests
... if higher education were to put a greater emphasis on commercialization of discoveries—perhaps even assigning commercialization the same level of importance as getting published and attracting grants” ... In the future, he hopes to further develop products for commercialization to effectively exploit the uses and opportunities of modern technology in education ...